A Clinical Trial Assessing the Safety and Efficacy of Biodegradable Magnesium Embolic Microspheres for Primary Hepatocellular Carcinoma

Clinical trial NCT06779461 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06779461
Sponsor: InnoBM Pharmaceuticals Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Non-Resectable

Start date: 2025-01-01
Primary completion: 2027-06-01
Enrollment: 228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.